Targeting heterogeneity in human Glioblastoma with mRNA-based Multispecific CAR-T Cells.

• Forschungsstelle: INNOSUISSE
• Projektnummer: 120.190 IP-LS
• Projekttitel Englisch: Targeting heterogeneity in human Glioblastoma with mRNA-based Multispecific CAR-T Cells.

Schlüsselwörter (Englisch)

Life sciences, Human medicine

Abstract (Englisch)

Cellula Therapeutics is dedicated to developing a multispecific, transient expression vector-based autologous CAR-T cell therapy for glioblastoma multiforme (GBM), a form of brain cancer with a median survival rate of less than 2 years after diagnosis.